Aptamers Market : Worldwide Market Assessments
The global aptamers market size is expected to witness significant growth during the forecast period, owing to increasing research and development activities by various biopharmaceutical companies and research institutes. For instance, in 2016, The Institute of Bioengineering and Nanotechnology (IBN) Singapore, invented an efficient DNA aptamers technology for detection and treatment of cancer and various infectious diseases such as dengue and malaria. Get more Insights (at) https://www.coherentmarketinsights.com/market-insight/aptamers-market-774
The global aptamers market size is expected to witness significant growth during the forecast period, owing to increasing research and development activities by various biopharmaceutical companies and research institutes. For instance, in 2016, The Institute of Bioengineering and Nanotechnology (IBN) Singapore, invented an efficient DNA aptamers technology for detection and treatment of cancer and various infectious diseases such as dengue and malaria.
Get more Insights (at) https://www.coherentmarketinsights.com/market-insight/aptamers-market-774
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
APTAMERS<br />
MARKET<br />
<strong>Market</strong> Size (2019)<br />
US$ 3626.13<br />
MN<br />
CAGR (2019 –<br />
2027)<br />
18.5%<br />
© Coherent <strong>Market</strong> Insights. All Rights Reserved
Segmentation (Scope)<br />
By Type By Application By End User<br />
<br />
<br />
Nucleic Acid <strong>Aptamers</strong><br />
• DNA-Based <strong>Aptamers</strong><br />
• RNA-Based <strong>Aptamers</strong><br />
• XNA-Based <strong>Aptamers</strong><br />
Peptide <strong>Aptamers</strong><br />
<br />
<br />
<br />
Diagnostics<br />
Therapeutics<br />
Research and<br />
Development<br />
<br />
<br />
<br />
Biotechnology & Pharmaceutical<br />
Companies<br />
Academic and Research<br />
Institutions<br />
Contract Research<br />
Organization<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Major Drivers<br />
Increasing number of applications<br />
Continuous investments and<br />
developments of novel aptamers<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
NORTH<br />
AMERICA<br />
<strong>Market</strong> Size<br />
US$ 1,588.24 MN<br />
CAGR<br />
18.9%<br />
ASIA<br />
PACIFIC<br />
<strong>Market</strong> Size<br />
US$ 678.0 MN<br />
CAGR<br />
19.1%<br />
Major Driver<br />
Owing to presence of major key players<br />
and adoption of strategic collaborations<br />
Major Driver<br />
Owing to increasing research and<br />
development in the field of aptamers<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
‣ Ophthotech Corporation<br />
‣ SomaLogic, Inc.<br />
‣ Aptus Biotech S.L.<br />
Major<br />
Players<br />
‣ Vivonics Inc.<br />
‣ Aptamer Sciences, Inc.<br />
‣ NeoNeuro SAS<br />
‣ AM Biotechnologies, LLC<br />
‣ Novartis AG<br />
‣ Aptagen, LLC<br />
‣ Base Pair Biotechnologies<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Global <strong>Aptamers</strong> <strong>Market</strong> Share (%) Analysis,<br />
By Type, 2019<br />
?<br />
?<br />
Nuclei Acid<br />
<strong>Aptamers</strong><br />
Peptide<br />
<strong>Aptamers</strong><br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Change language